Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-09 Sale |
2023-01-11 4:05 pm |
Homology Medicines Inc. | FIXX | Smith W Bradford See Remarks |
3,729 | $1.3912 | $5,188 | 14,219 (Direct) |
View |
| 2022-01-05 Sale |
2022-01-12 4:05 pm |
Homology Medicines Inc. | FIXX | Smith W Bradford CFO & Treasurer |
2,182 | $3.7802 | $8,248 | 17,818 (Direct) |
View |
| 2021-02-08 Sale |
2021-02-09 4:22 pm |
Homology Medicines Inc. | FIXX | Smith W Bradford CFO & Treasurer |
13,500 | $14.25 | $192,425 | 243,904 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-13 Option Award |
2024-06-14 4:10 pm |
N/A 2034-06-12 |
Lyra Therapeutics Inc. | LYRA | Smith W Bradford Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:52 pm |
N/A 2033-06-29 |
Lyra Therapeutics Inc. | LYRA | Smith W Bradford Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 4:05 pm |
N/A 2033-02-23 |
Homology Medicines Inc. | FIXX | Smith W Bradford See remarks |
249,000 | $0 | 249,000 (Direct) |
View |
| 2023-01-01 Exercise |
2023-01-04 4:34 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Smith W Bradford See Remarks |
13,530 | $0 | 38,818 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 4:06 pm |
N/A 2032-06-15 |
Lyra Therapeutics Inc. | LYRA | Smith W Bradford Director |
7,250 | $0 | 7,250 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 4:06 pm |
N/A 2032-02-24 |
Homology Medicines Inc. | FIXX | Smith W Bradford CFO & Treasurer |
147,000 | $0 | 147,000 (Direct) |
View |
| 2022-01-01 Exercise |
2022-01-12 4:05 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Smith W Bradford CFO & Treasurer |
6,600 | $0 | 17,818 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 6:23 pm |
N/A 2031-05-25 |
Lyra Therapeutics Inc. | LYRA | Smith W Bradford Director |
7,250 | $0 | 7,250 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 4:22 pm |
N/A 2031-02-05 |
Homology Medicines Inc. | FIXX | Smith W Bradford CFO & Treasurer |
142,000 | $0 | 243,904 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-09 4:22 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Smith W Bradford CFO & Treasurer |
13,500 | $0.64 | 243,904 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-09 4:22 pm |
N/A 2027-04-05 |
Homology Medicines Inc. | FIXX | Smith W Bradford CFO & Treasurer |
13,500 | $0 | 243,904 (Direct) |
View |
Ownership |
2020-04-30 7:11 pm |
N/A 2030-02-06 |
Lyra Therapeutics Inc. | LYRA | Smith W Bradford Director |
0 | $0 | 13,289 (Direct) |
View |